Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-23-081147
Filing Date
2023-07-14
Accepted
2023-07-14 14:15:02
Documents
7
Effectiveness Date
2023-07-14

Document Format Files

Seq Description Document Type Size
1 S-8 tm2320962d1_s8.htm S-8 45828
2 EXHIBIT 5.1 tm2320962d1_ex5-1.htm EX-5.1 25849
3 EXHIBI 23.1 tm2320962d1_ex23-1.htm EX-23.1 2383
4 EX-FILING FEES tm2320962d1_ex-fillingfees.htm EX-FILING FEES 19020
5 GRAPHIC tm2320962d1_ex23-1img001.jpg GRAPHIC 2890
6 GRAPHIC tm2320962d1_ex5-1img003.jpg GRAPHIC 4679
7 GRAPHIC tm2320962d1_ex5-1img004.jpg GRAPHIC 3282
  Complete submission text file 0001104659-23-081147.txt   109546
Mailing Address 77 KING STREET WEST, SUITE 400 C/O DENTONS CANADA LLP TORONTO A6 M5K 0A1
Business Address 1A, 1B LEAROYD ROAD NEW ROMNEY X0 TN28 8XU 442034889514
AKANDA CORP. (Filer) CIK: 0001888014 (see all company filings)

EIN.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-273245 | Film No.: 231088777
SIC: 2833 Medicinal Chemicals & Botanical Products